Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease von Smid, Bouwien E, van der Tol, Linda, Biegstraaten, Marieke, Linthorst, Gabor E, Hollak, Carla E M, Poorthuis, Ben J H M

Volltext

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain von Rombach, Saskia M, Smid, Bouwien E, Bouwman, Machtelt G, Linthorst, Gabor E, Dijkgraaf, Marcel G W, Hollak, Carla E M

Volltext

Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients von Smid, Bouwien E, Rombach, Saskia M, Aerts, Johannes M F G, Kuiper, Symen, Mirzaian, Mina, Overkleeft, Hermen S, Poorthuis, Ben J H M, Hollak, Carla E M, Groener, Johanna E M, Linthorst, Gabor E

Volltext

Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta‐analysis von Rombach, Saskia M., Smid, Bouwien E., Linthorst, Gabor E., Dijkgraaf, Marcel G. W., Hollak, Carla E. M.

Volltext

Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease von Shu, Liming, Vivekanandan-Giri, Anuradha, Pennathur, Subramaniam, Smid, Bouwien E., Aerts, Johannes M.F.G., Hollak, Carla E.M., Shayman, James A.

Volltext

Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: Effectiveness of ERT in different disease stages von Rombach, Saskia M., Smid, Bouwien E., Linthorst, Gabor E., Dijkgraaf, Marcel G. W., Hollak, Carla E. M.

Volltext

Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients von Smid, Bouwien E, Ferraz, Maria J, Verhoek, Marri, Mirzaian, Mina, Wisse, Patrick, Overkleeft, Herman S, Hollak, Carla E, Aerts, Johannes M

Volltext

Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy von Suntjens, Eefje B., Smid, Bouwien E., Biegstraaten, Marieke, Dreschler, Wouter A., Hollak, Carla E. M., Linthorst, Gabor E.

Volltext